Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120
LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. LMAT | 0.00 |
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:
LMAT) with a Outperform and raises the price target from $105 to $120.